Company Profile For GlaxoSmithKline PLC

GlaxoSmithKline plc (GSK) is a global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK’s principal pharmaceutical products include medicines in the therapeutic areas, such as respiratory, central nervous system, anti-virals, anti-bacterials, metabolic, vaccines, cardiovascular and urogenital, oncology and emesis. It has operations in some 114 countries and products sold in over 150 countries. The Company operates in two segments: Pharmaceuticals (prescription pharmaceuticals and vaccines) and Consumer Healthcare. On October 14, 2008, it acquired the Egyptian mature products business of Bristol Myers Squibb Company (BMS). In July 2009, BMS' branded generics business, which comprises a portfolio of 13 branded pharmaceuticals was acquired by the Company. In July 2009, GSK acquired Stiefel Laboratories, Inc.

BRIEF: For the nine months ended 30 June 2009, GlaxoSmithKline plc's revenues increased 16% to £20.27B. Net income increased 8% to £3.9B. Revenues reflect an increase in sales from Consumer Healthcare and Pharmaceuticals business division. Net income was partially offset by an increase in cost of sales, increased selling, general & administration expenses, higher research & development expenses and higher finance expenses.